( can bedifficult to diagnose(1) and may...)Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder,Health

"This study underscores the importance of treating all of the many symptoms of GAD and reducing the global functional impairment associated with the disorder," says Dr. David Sheehan, lead study author and professor of psychiatry at the University of South Florida College of Medicine in Tampa. "This information may be important for physicians to consider when choosing a treatment for their patients with GAD since different medications may affect symptoms differently."

    Additional Study Highlights

    --  Thirty-six percent of the improvement in global functioning was due to

        an undefined effect of Cymbalta, which was not measured on any of the

        three scales used in the study.

    --  In improvement in work functioning, 36 percent was due to treatment of

        psychic anxiety, 8 percent was due to treatment of painful

        physical symptoms and 4 percent was due to treatment of somatic

        anxiety, while 51 percent was due to an undefined effect of Cymbalta.

    --  In improvement in social functioning, 46 percent of the improvement

        was due to treatment of psychic anxiety, 9 percent was due to

        treatment of painful physical symptoms and 6 percent was due to

        treatment of somatic anxiety, while 39 percent was due to an

        unexplained effect of Cymbalta.

    --  In improvement in family life functioning, 51 percent of the

        improvement was due to treatment of psychic anxiety, 10 percent was

        due to treatment of painful physical symptoms and 10 percent was due

        to treatment of somatic anxiety, while 30 percent was due to an

        undefined effect of Cymbalta.

    --  In the pooled analyses of all the GAD registration studies, the most

        commonly observed adverse events (incidence of 5 percent or greater

     
'"/>




Page: 1 2 3 4 5 6 
Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe
Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able
to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise
for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab)
May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for
Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical
Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation
in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action
Relevant to Broad Range of Chronic Inflammatory Diseases - Human
Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work
Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER
Sirolimus-Eluting Coronary Stent than with Taxus Stent in
Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With
Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night
Balance, Mobility or Memory in Older Adults Using Ramelteon